Company Valuation: Hubei Jumpcan Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 17,969 25,173 25,092 28,972 26,803 25,061 25,061
Change - 40.09% -0.32% 15.46% -7.49% -6.5% 0%
Enterprise Value (EV) 17,969 25,173 25,092 28,972 26,803 25,061 25,061
Change - 40.09% -0.32% 15.46% -7.49% -6.5% 0%
P/E ratio 13.2x 15.2x 11.4x 10.2x 10.5x - -
PBR 2.35x 2.78x 2.21x 2.17x 1.82x - -
PEG - 0.7x 0.4x 0.4x -1x - -
Capitalization / Revenue 29,14,764x 32,99,025x 27,89,126x 30,00,909x 33,43,334x - -
EV / Revenue - - - - - - -
EV / EBITDA - - - - - - -
EV / EBIT - - - - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 1.53 1.87 2.39 3.08 2.76 - -
Distribution rate - - - - - - -
Net sales 6,165 7,631 8,996 9,655 8,017 - -
EBITDA - 2,226 2,740 3,209 - - -
EBIT 1,469 1,871 2,423 3,258 2,863 - -
Net income 1 1,277 1,664 2,171 2,823 2,532 1,547 1,724
Net Debt - - - - - - -
Reference price 2 20.23 28.34 27.22 31.43 29.08 27.20 27.20
Nbr of stocks (in thousands) 8,88,257 8,88,259 9,21,822 9,21,807 9,21,704 9,21,344 9,21,344
Announcement Date 16/04/21 19/01/22 19/01/23 09/04/24 25/04/25 - -
1CNY in Million2CNY
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 362.64Cr
29.14x1.54x9.94x3.13% 616.81Cr
20.18x4.4x14.7x4.58% 513.74Cr
15.45x - - - 452.24Cr
23.91x3.18x18.07x1.41% 430.57Cr
18.73x2.21x9.67x4.78% 323.41Cr
15.9x2.89x12.32x4.97% 179.85Cr
18.66x - - 4.4% 173.14Cr
Average 20.28x 2.84x 12.94x 3.88% 381.55Cr
Weighted average by Cap. 21.48x 2.81x 12.99x 3.62%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 600566 Stock
  4. Valuation Hubei Jumpcan Pharmaceutical Co., Ltd.